1. Home
  2. RMNI vs HELP Comparison

RMNI vs HELP Comparison

Compare RMNI & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rimini Street Inc. (DE)

RMNI

Rimini Street Inc. (DE)

HOLD

Current Price

$3.94

Market Cap

307.1M

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$5.35

Market Cap

279.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RMNI
HELP
Founded
2005
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.1M
279.9M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
RMNI
HELP
Price
$3.94
$5.35
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$5.00
$51.50
AVG Volume (30 Days)
406.9K
1.5M
Earning Date
04-30-2026
07-01-2026
Dividend Yield
N/A
N/A
EPS Growth
197.50
N/A
EPS
0.01
N/A
Revenue
$431,496,000.00
N/A
Revenue This Year
$6.02
N/A
Revenue Next Year
$5.50
N/A
P/E Ratio
$388.50
N/A
Revenue Growth
5.33
N/A
52 Week Low
$2.87
$4.29
52 Week High
$5.38
$8.55

Technical Indicators

Market Signals
Indicator
RMNI
HELP
Relative Strength Index (RSI) 64.46 49.69
Support Level $3.91 $4.63
Resistance Level $4.15 $6.26
Average True Range (ATR) 0.14 0.50
MACD 0.04 0.01
Stochastic Oscillator 74.85 34.43

Price Performance

Historical Comparison
RMNI
HELP

About RMNI Rimini Street Inc. (DE)

Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. The company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management, database, and technology software systems. Geographically, the company generates its revenue from the United States of America and the International market.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: